V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10005807 | 10003660 | 1.6 | 78.9 | Not known (9) | 2016-03-23 | 2016-04-04 | PEMBROLIZUMAB | N | N | 10279378 | PEMBROLIZUMAB |
| 10005808 | 10003661 | null | 78.4 | Palliative (P) | 2017-08-29 | 2018-07-07 | Trastuzumab Subcutaneous | 02 | N | 10279595 | TRASTUZUMAB |
| 10005809 | 10003663 | 1.77 | 94.6 | Disease modification (D) | 2018-10-22 | 2018-12-30 | Paclitaxel 7 day | N | N | 10279645 | PACLITAXEL |
| 10005810 | 10003664 | 1.57 | 57 | Palliative (P) | 2016-08-27 | 2017-10-31 | Irinotecan + Modified De Gramont | N | N | 10279696 | IRINOTECAN + MDG |
| 10005811 | 10003665 | 1.77 | 95.2 | Palliative (P) | 2018-02-25 | 2018-03-03 | Docetaxel | N | N | 10279818 | DOCETAXEL |
| 10005812 | 10003667 | 1.78 | 75.8 | Adjuvant (A) | 2014-02-11 | 2014-04-05 | Rituximab | 2 | N | 10280029 | RITUXIMAB |
| 10005813 | 10003668 | 1.71 | 78.5 | null | 2018-05-29 | 2018-05-29 | Docetaxel | N | N | 10280094 | DOCETAXEL |
| 10005814 | 10003669 | 1.75 | null | Neo-adjuvant (N) | 2016-07-11 | 2016-07-15 | PACLITAXEL | N | N | 10280144 | PACLITAXEL |
| 10005815 | 10003669 | 1.72 | 75.199 | Palliative (P) | 2017-01-22 | 2017-02-05 | CHOP R - 21 days | 02 | null | 10280144 | CHOP R |
| 10005816 | 10003669 | 1.74 | 0 | Curative (C) | 2018-07-18 | 2018-08-09 | Irinotecan + Modified De Gramont | 2 | N | 10280144 | IRINOTECAN + MDG |
| 10005817 | 10003669 | 1.7 | 78 | Adjuvant (A) | 2016-05-08 | 2016-05-08 | TRASTUZUMAB | N | N | 10280144 | TRASTUZUMAB |
| 10005818 | 10003670 | 1.8 | 82.7 | Adjuvant (A) | 2014-11-10 | 2014-11-22 | Docetaxel | N | N | 10280576 | DOCETAXEL |
| 10005819 | 10003670 | 1.87 | 69.5 | M | 2013-07-06 | 2013-07-06 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 10280576 | PACLITAXEL |
| 10005820 | 10003671 | 1.67 | 57.4 | Adjuvant (A) | 2016-11-02 | 2016-11-03 | CAPECITABINE + OXALIPLATIN | N | N | 10280855 | CAPECITABINE + OXALIPLATIN |
| 10005821 | 10003673 | 1.7 | 104 | Palliative (P) | 2016-11-15 | 2017-01-20 | Rituximab | 2 | N | 10280926 | RITUXIMAB |
| 10005822 | 10003673 | 1.82 | 82.2 | Adjuvant (A) | 2019-03-09 | 2019-03-09 | Trastuzumab Subcutaneous | 02 | N | 10280926 | TRASTUZUMAB |
| 10005823 | 10003675 | 1.87 | 68.2 | Curative (C) | 2015-09-03 | 2015-09-03 | Rituximab | N | N | 10281194 | RITUXIMAB |
| 10005824 | 10003677 | 1.71 | 71.3 | Palliative (P) | 2015-08-03 | 2015-08-03 | Oxaliplatin + Modified de Gramont | 02 | N | 10281315 | OXALIPLATIN + MDG |
| 10005825 | 10003679 | null | 67.4 | Adjuvant (A) | 2018-04-06 | 2018-04-08 | CHOP R - 21 days | 02 | N | 10281340 | CHOP R |
| 10005826 | 10003679 | 1.79 | 74.2 | null | 2018-03-24 | 2018-03-24 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 10281340 | PACLITAXEL |
| 10005827 | 10003679 | null | 69.8 | Disease modification (D) | 2017-04-27 | 2017-04-28 | Rituximab | N | N | 10281340 | RITUXIMAB |
| 10005828 | 10006983 | 1.7 | 80 | Palliative (P) | 2018-02-11 | 2018-03-10 | Capecitabine + Oxaliplatin 21day | N | N | 10282069 | CAPECITABINE + OXALIPLATIN |
| 10005829 | 10003681 | 1.65 | 88 | null | 2016-07-19 | 2016-07-26 | Rituximab | N | null | 10282124 | RITUXIMAB |
| 10005830 | 10003681 | 1.85 | 61.9 | Adjuvant (A) | 2017-12-10 | 2018-01-13 | CHOP R | 02 | N | 10282124 | CHOP R |
| 10005831 | 10003682 | 1.5 | 63 | Palliative (P) | 2013-11-04 | 2013-11-09 | Rituximab | N | N | 10282414 | RITUXIMAB |
| 10005832 | 10006986 | null | 50.3 | Palliative (P) | 2017-08-17 | 2017-09-14 | TRASTUZUMAB | N | Y | 10282675 | TRASTUZUMAB |
| 10005833 | 10006986 | 0 | null | Curative (C) | 2018-01-15 | 2018-01-22 | CHOP R - 21 days | 02 | null | 10282675 | CHOP R |
| 10005834 | 10003684 | 1.7 | 57.3 | Palliative (P) | 2017-11-22 | 2017-11-23 | Irinotecan + Modified De Gramont | 02 | N | 10282824 | IRINOTECAN + MDG |
| 10005835 | 10003685 | 1.51 | 59 | Palliative (P) | 2017-08-04 | 2017-08-09 | FLUOROURACIL + OXALIPLATIN | 02 | N | 10282824 | OXALIPLATIN + MDG |
| 10005836 | 10003687 | 1.62 | 71.6 | Adjuvant (A) | 2017-07-19 | 2017-08-04 | Capecitabine + Oxaliplatin 21day | 02 | N | 10282967 | CAPECITABINE + OXALIPLATIN |
| 10005837 | 10003688 | null | 76.6 | Palliative (P) | 2017-11-16 | 2018-04-01 | Capecitabine + Oxaliplatin 21day | N | N | 10282967 | CAPECITABINE + OXALIPLATIN |
| 10005838 | 10003690 | 1.8 | 82 | Not known (9) | 2014-08-25 | 2014-09-07 | FLUOROURACIL + IRINOTECAN | 2 | N | 10283619 | IRINOTECAN + MDG |
| 10005839 | 10003695 | null | 77 | Disease modification (D) | 2017-03-13 | 2017-03-19 | FLUOROURACIL + IRINOTECAN | null | null | 10283675 | IRINOTECAN + MDG |
| 10005840 | 10003695 | 1.78 | 0 | Disease modification (D) | 2016-10-08 | 2016-10-12 | TRASTUZUMAB | 02 | Y | 10283675 | TRASTUZUMAB |
| 10005841 | 10003696 | null | 61.5 | Palliative (P) | 2016-12-02 | 2016-12-17 | Rituximab | 2 | N | 10283957 | RITUXIMAB |
| 10005842 | 10003699 | 1.76 | 68.3 | Disease modification (D) | 2017-10-29 | 2017-11-19 | Trastuzumab Subcutaneous | 02 | null | 10284128 | TRASTUZUMAB |
| 10005843 | 10006991 | 1.72 | 59.6 | Palliative (P) | 2017-10-18 | 2017-10-20 | TRASTUZUMAB | N | null | 10284374 | TRASTUZUMAB |
| 10005844 | 10003701 | 1.77 | 70 | Palliative (P) | 2018-02-01 | 2018-02-03 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 10284374 | RITUXIMAB |
| 10005845 | 10003702 | 1.67 | 67.1 | Palliative (P) | null | 2016-11-24 | Trastuzumab 21 day maintenance | 2 | N | 10285163 | TRASTUZUMAB |
| 10005846 | 10003704 | 1.6 | 94.15 | Palliative (P) | 2017-03-16 | 2017-03-22 | CAPECITABINE + OXALIPLATIN | N | N | 10285240 | CAPECITABINE + OXALIPLATIN |
| 10005847 | 10003705 | 1.65 | 66.6 | Palliative (P) | 2016-10-27 | 2016-11-10 | Rituximab (Maintenance) | 2 | N | 10285489 | RITUXIMAB |
| 10005848 | 10003707 | 1.78 | 80 | Adjuvant (A) | 2014-12-06 | 2015-02-09 | CHOP R | N | N | 10285489 | CHOP R |
| 10005849 | 10006996 | 1.64 | 110 | Curative (C) | 2017-12-09 | 2018-01-18 | TRASTUZUMAB | 02 | N | 10285724 | TRASTUZUMAB |
| 10005850 | 10003710 | 1.65 | 101 | Palliative (P) | 2018-10-12 | 2018-10-12 | Capecitabine + Oxaliplatin 21day | 2 | N | 10285987 | CAPECITABINE + OXALIPLATIN |
| 10005851 | 10003710 | 1.8 | 76.6 | Palliative (P) | 2019-02-22 | 2019-02-24 | CHOP R | 02 | N | 10285987 | CHOP R |
| 10005852 | 10003711 | 1.7 | 53.1 | Adjuvant (A) | 2015-03-20 | 2015-03-30 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 10286064 | PACLITAXEL |
| 10005853 | 10003712 | 1.7 | 49.45 | Not known (9) | 2017-01-02 | 2017-03-31 | CHOP R - 21 days | 2 | N | 10286080 | CHOP R |
| 10005854 | 10003713 | 1.6 | 62.4 | Adjuvant (A) | 2018-12-02 | 2018-12-08 | Docetaxel 75mg/m2 (21 day) | N | N | 10286363 | DOCETAXEL |
| 10005855 | 10003714 | 1.76 | 84.8 | Adjuvant (A) | 2018-01-05 | 2018-01-06 | Docetaxel 100mg/m2 (21 day) | N | N | 10286369 | DOCETAXEL |
| 10005856 | 10003715 | 1.83 | 66.4 | Palliative (P) | 2019-06-11 | 2019-08-29 | PEMBROLIZUMAB | 02 | N | 10286491 | PEMBROLIZUMAB |